Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma and saliva pharmacokinetics of immediate-release and OROS methylphenidate in healthy volunteers
NL-OMON34088Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Saliva methylphenidate concentrations, Effect of saliva pH on saliva methylphenidate concentration and 2 more. Started May 2010; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON34088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34088.